Hypertension in women with polycystic ovary syndrome: prevalence and associated cardiovascular risk factors.
To determine the prevalence of hypertension in women with polycystic ovary syndrome (PCOS). Women with PCOS (n=3396) and controls (n=1891) from a Han Chinese population were analysed retrospectively in terms of ovarian appearance on ultrasound, glucose tolerance test, hormones, lipoproteins, anthropomorphic measurements and blood pressure. The prevalence of hypertension was 19.2% in the women with PCOS, which was much higher than that in the controls (11.9%). After matching for body mass index, the hypertensive PCOS group had higher glucose, insulin, homeostatic model assessment (HOMA-IR) and lipid levels than the normotensive PCOS group; these differences were significant (p<0.05). Hypertensive PCOS patients had higher lipid, insulin and glucose levels than normotensive PCOS patients. It is likely that the incidence of long-term complications will be higher among the former group.